LFVN

LifeVantage Corporation

$4.56

-13.80%
SectorConsumer DefensiveIndustryPackaged FoodsCountryUnited States

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally.

Source: Yahoo Finance
AI summary

Price & performance

1M-24.0%
3M-31.2%
YTD-22.5%
1Y-35.2%
52-week range—
Beta0.89
Full chart and returns against a benchmark

Q-Score

58/ 100

Quality against peers; 50 is the peer median.

Growth35
Risk39
Performance52
Valuation70
Profitability75
Leverage72
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2026

Revenue$182.6M-20.1%
Net income$5.1M-48.3%
Net margin2.8%-1.5 pts
Historical fundamentals

Revenue exposure

26%of revenue from outside the US
United States74%
Japan13%
Other Foreign13%
Regions, segments, customers and suppliers

Valuation

LFVNIndustryP/E21.1053.49P/S0.330.75EV/EBITDA6.6316.50P/B1.731.61PEG—5.24
Dividend yield4.18%
Every valuation metric

Earnings

Feb 4next report, after the close
EPS estimate$0.06
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate